The HIV estimates, which are released on an annual basis using the Spectrum Estimation and Projection Package Model, revealed that about 79 627 men and 148 911 women are living with HIV in Namibia.

Patients presenting to emergency departments with opioid overdose have high rates of hepatitis C virus (HCV) infection, ...

From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus ...

HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...

Key targets include achieving 95 percent diagnosis, treatment, and viral load suppression among people living with HIV, as ...

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

Gilead Sciences, Inc. today announced the presentation of new research data from its innovative HIV treatment portfolio and pipeline, including a broad range of data on investigational and marketed ...

The study evaluated the efficacy and safety of Dovato in 230 antiretroviral treatment-naïve individuals with advanced HIV.

Encouraging findings with immunotherapy aiming at ART-free virological control A significant step towards functional cure of HIV infection ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...

A post-hoc analysis of the study showed DTG/3TC was non-inferior to 3-drug therapy regardless of the participant’s baseline viral load. These data were presented at HIV Glasgow 2024, being held in ...